Mangoceuticals, inc. announces 1-for 15 reverse stock split as part of nasdaq compliance plan

Dallas, tx, oct. 11, 2024 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ed), hair growth, weight loss, and hormone replacement therapies, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-15 (the “reverse stock split”). the reverse stock split will become effective on october 16, 2024 at 12:01 a.m. eastern time (the “effective time”), with shares expected to begin trading on the nasdaq capital market, on a split-adjusted basis, at market open on october 16, 2024. in connection with the reverse stock split, every fifteen shares of the company's common stock issued and outstanding as of the effective time will be automatically converted into one share of the company's common stock. no change will be made to the trading symbol for the company's shares of common stock, “mgrx”, in connection with the reverse split.
MGRX Ratings Summary
MGRX Quant Ranking